Prevalence and Risk Factors for Augmented Renal Clearance in a Population of Critically Ill Patients

被引:28
|
作者
Baptista, Joao Pedro [1 ]
Martins, Paulo Jorge [1 ]
Marques, Margarida [2 ]
Pimentel, Jorge Manuel [1 ]
机构
[1] Ctr Hosp & Univ Coimbra CHUC, Dept Intens Care, Coimbra, Portugal
[2] Ctr Hosp & Univ Coimbra CHUC, Dept Stat, Coimbra, Portugal
关键词
critical care; epidemiology; augmented renal clearance; risk; creatinine clearance; antibiotics; CREATININE CLEARANCE; ICU; HYPERFILTRATION; WEIGHT;
D O I
10.1177/0885066618809688
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: Critically ill patients show a high, albeit variable, prevalence of augmented renal clearance (ARC). This condition has relevant consequences on the elimination of hydrophilic drugs. Knowledge of risk factors for ARC helps in the early identification of ARC. The aims of this study were evaluation of (1) risk factors for ARC and (2) the prevalence of ARC in critically ill patients over a period of 1 year. Methods: A retrospective cohort study was performed for all consecutive patients admitted to our intensive care unit (ICU). Augmented renal clearance was defined by a creatinine clearance >= 130 mL/min/1.73 m(2). "Patient with ARC" was defined as a patient with a median of creatinine clearance >= 130 mL/min/1.73 m(2)over the period of admission. Four variables were tested, Simplified Acute Physiology Score II (SAPS II), male gender, age, and trauma as cause for ICU admission. An analysis (patient based and clearance based) was performed with logistic regression. Results: Of 475 patients, 446 were included in this study, contributing to 454 ICU admissions and 5586 8-hour creatinine clearance (8h-CLCR). Overall, the prevalence of patients with ARC was 24.9% (n = 113). In a subset of patients with normal serum creatinine levels, the prevalence was 43.0% (n = 104). Of the set of all 8h-CL(CR)measurements, 25.4% (1418) showed ARC. In the patient-based analysis, the adjusted odds ratio was: 2.0 (confidence interval [CI]:1.1-3.7;P< .05), 0.93 (CI: 0.91-0.94;P< .01), 2.7 (CI: 1.4-5.3;P< .01), and 0.98 (CI: 0.96 -1.01;P= .15), respectively, for trauma, age, male sex, and SAPS II. In the clearance-based analysis, the adjusted odds ratio were 1.7 (CI: 1.4-1.9;P< .01), 0.94 (CI: 0.932-0.942;P< .01), and 2.9 (CI: 2.4-3.4;P< .01), respectively, for trauma, age, and male sex. Conclusions: Trauma, young age, and male sex were independent risk factors for ARC. This condition occurs in a considerable proportion of critical care patients, which was particularly prevalent in patients without evidence of renal dysfunction.
引用
收藏
页码:1044 / 1052
页数:9
相关论文
共 50 条
  • [21] A higher dose of vancomycin is needed in critically ill patients with augmented renal clearance
    He, Juan
    Yang, Zhi-Tao
    Qian, Xian
    Zhao, Bing
    Mao, En-Qiang
    Chen, Er-Zhen
    Bian, Xiao-Lan
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2020, 9 (05) : 2166 - 2171
  • [22] A comparison of estimates of glomerular filtration in critically ill patients with augmented renal clearance
    Baptista, Joao Pedro
    Udy, Andrew A.
    Sousa, Eduardo
    Pimentel, Jorge
    Wang, Lisa
    Roberts, Jason A.
    Lipman, Jeffrey
    CRITICAL CARE, 2011, 15 (03):
  • [23] THE IMPACT OF AUGMENTED RENAL CLEARANCE ON VANCOMYCIN THERAPY IN CRITICALLY ILL TRAUMA PATIENTS
    Rice, Timothy
    Droege, Christopher
    Droege, Molly
    Mueller, Eric
    Ernst, Neil
    Liao, Siyun
    Goodman, Michael
    CRITICAL CARE MEDICINE, 2022, 50 (01) : 779 - 779
  • [24] Pharmacokinetics and Pharmacodynamics of Ceftolozane/Tazobactam in Critically Ill Patients With Augmented Renal Clearance
    Nicolau, David P.
    De Waele, Jan
    Kuti, Joseph L.
    Caro, Luzelena
    Larson, Kajal B.
    Yu, Brian
    Gadzicki, Elaine
    Zeng, Zhen
    Rhee, Elizabeth G.
    Rizk, Matthew L.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2021, 57 (04)
  • [25] SCOPING REVIEW OF AUGMENTED RENAL CLEARANCE (ARC) IN CRITICALLY ILL PEDIATRIC PATIENTS
    Rhoney, Denise
    Metzger, Sam
    Nelson, Nicholas
    CRITICAL CARE MEDICINE, 2021, 49 (01) : 426 - 426
  • [26] The Impact of Augmented Renal Clearance on Vancomycin Pharmacokinetics and Pharmacodynamics in Critically Ill Patients
    Tesfamariam, Novel Solomon
    Aboelezz, Asma
    Mahmoud, Sherif Hanafy
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (08)
  • [27] A comparison of estimates of glomerular filtration in critically ill patients with augmented renal clearance
    João Pedro Baptista
    Andrew A Udy
    Eduardo Sousa
    Jorge Pimentel
    Lisa Wang
    Jason A Roberts
    Jeffrey Lipman
    Critical Care, 15
  • [28] Augmented Renal Clearance Implications for Antibacterial Dosing in the Critically Ill
    Udy, Andrew A.
    Roberts, Jason A.
    Boots, Robert J.
    Paterson, David L.
    Lipman, Jeffrey
    CLINICAL PHARMACOKINETICS, 2010, 49 (01) : 1 - 16
  • [29] Augmented Renal Clearance in Critically Ill: Advantage or Threat Reply
    Udy, Andrew A.
    Baptista, Joao P.
    Lim, Noelle L.
    Joynt, Gavin M.
    Jarrett, Paul
    Boots, Robert J.
    Lipman, Jeffrey
    CRITICAL CARE MEDICINE, 2014, 42 (08) : E602 - E603
  • [30] AUGMENTED RENAL CLEARANCE: SURPRISINGLY COMMON IN CRITICALLY ILL CHILDREN
    Van Der Heggen, Tatjana
    Dhont, Evelyn
    Vande Walle, Johan
    De Paepe, Peter
    De Cock, Pieter
    PEDIATRIC NEPHROLOGY, 2018, 33 (10) : 1886 - 1886